Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: From the 10-K (Note in bold)

Pursuant to the Master Agreement, PDS has committed to pay a quarterly amount

Is this at the sole discretion of PDS management? If so, PDS management is Dan Leckrone and Carlton Johnson. Doesn't it seem odd that PTSC said it will not make any more loans to TPL and then Carl and Dan approve quarterly payments to Leckrone to the tune of $2,500,000? Then TPL submits and is paid for expenses in excess of $6 million (which includes "other expenses"). Leckrone is taking it to the bank(s) wherever those banks may be, he doesn't need another stinking loan from PTSC as long as Carl is in the position to approve these payments to Dan.

Share
New Message
Please login to post a reply